Not Rated
Fund Size
(0.08% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 23-Sep-25 | 9689.70 | -3.10% | - | -2.53% | 181/237 |
1 Month | 29-Aug-25 | 9844.20 | -1.56% | - | 1.11% | 210/236 |
3 Month | 30-Jun-25 | 9989.70 | -0.10% | - | -1.75% | 57/227 |
6 Month | 28-Mar-25 | 10611.30 | 6.11% | - | 8.66% | 148/223 |
YTD | 01-Jan-25 | 9809.20 | -1.91% | - | 0.65% | 130/212 |
1 Year | 30-Sep-24 | 10407.10 | 4.07% | 4.07% | -5.21% | 16/193 |
Since Inception | 06-Feb-24 | 13522.00 | 35.22% | 20.07% | 11.31% | 21/212 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 30-Sep-24 | 12000 | 12385.47 | 3.21 % | 5.98 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd. | Hospital | 296 | 6.99% | -0.71% | 7.97% (Jun 2025) | 2.76% (Sep 2024) | 2.56 L | 3.30 k |
J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 288 | 6.80% | 2.21% | 6.8% (Aug 2025) | 0% (Sep 2024) | 1.67 L | 60.88 k |
Fortis Healthcare Ltd. | Hospital | 265.6 | 6.27% | 0.94% | 6.27% (Aug 2025) | 1.1% (Sep 2024) | 2.91 L | 36.86 k |
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 257.9 | 6.09% | -0.55% | 11.31% (Apr 2025) | 6.09% (Aug 2025) | 1.62 L | 2.52 k |
Cipla Ltd. | Pharmaceuticals | 208.6 | 4.92% | 0.14% | 8.07% (Feb 2025) | 4.15% (Sep 2024) | 1.31 L | 5.29 k |
Laurus Labs Ltd. | Pharmaceuticals | 178.2 | 4.21% | -0.23% | 4.44% (Jul 2025) | 0% (Sep 2024) | 2.08 L | 0.00 |
Krishna Institute of Medical Sciences Ltd. | Hospital | 161.2 | 3.81% | -0.07% | 3.91% (Jun 2025) | 2.63% (Oct 2024) | 2.23 L | 11.06 k |
Apollo Hospitals Enterprises Ltd. | Hospital | 138.6 | 3.27% | 0.34% | 3.27% (Aug 2025) | 2.07% (Oct 2024) | 18.22 k | 2.23 k |
Vijaya Diagnostic Centre Ltd. | Healthcare service provider | 110.5 | 2.61% | 0.54% | 2.61% (Aug 2025) | 0.42% (May 2025) | 1.10 L | 30.70 k |
Neuland Laboratories Ltd. | Pharmaceuticals | 107.1 | 2.53% | 1.06% | 2.53% (Aug 2025) | 1.3% (Feb 2025) | 7.96 k | 3.44 k |
Investment / Portfolio Grades
Security Type |
% Weight |
Category Average |
---|---|---|
Government Backed | 3.01% | 0.48% |
Low Risk | 0.00% | 0.00% |
Moderate Risk | 0.00% | 0.00% |
High Risk | 0.00% | 0.00% |
Very High Risk | 0.00% | 0.00% |
Others | 0.00% | 0.00% |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 7.00% |
Net Receivables | Net Receivables | 0.28% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 20 mutual fund schemes offered by this AMC, 1 is/are ranked 4 * , and 19 schemes are not ranked. See more about AMC